Viokace Tablet
Product Images NDC 73562-208

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Viokace (NDC 73562-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aimmune Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Lipase 10,440 USP Units)

Viokace (pancrelipase) tablets label showing a dosage form of tablets with enzyme activity strengths of 10,440 USP Units Lipase, 39,150 USP Units Amylase, and 39,150 USP Units Protease per tablet. The bottle contains 100 tablets. Distributed by Nestlé HealthCare Nutrition, Inc. with storage and usage instructions on the label, including swallowing tablets whole and protecting from moisture.*

FDA Label Image

Principal Display Panel (Lipase 20,880 USP Units)

Viokace (pancrelipase) tablets label showing each tablet contains 20,880 USP Units Lipase, 78,300 USP Units Amylase, and 78,300 USP Units Protease. The product is distributed by Nestlé HealthCare Nutrition, Inc., manufactured in Canada, with NDC 73562-208-10 and a package containing 100 tablets. Instructions note to swallow tablets whole and storage conditions at 20-25°C (68-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.